Abstract
CONJUGATION of catecholamines in man was first described for adrenaline by Richter in 19401. He suggested that the conjugated product was an ester of sulphuric acid. Richter and MacIntosh2 later demonstrated that conjugation of adrenaline markedly reduced its presser properties and proposed that conjugation is a mechanism of inactivation of the biological properties of this amine. Holtz and Credner3 administered L-dopa to several animals including man and isolated both free and conjugated dopamine (DA) from urine. Conjugation of two metabolites of DA, homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC), was observed by Shaw, McMillan and Armstrong4 when they isolated these two phenolic acids from the urine of human subjects who had received L-dopa orally. The conjugates of these compounds can be isolated by anion exchange chromatography5,6. When conjugated derivatives in the eluates from anion exchange columns were hydrolysed by sulphuric acid5,6 or sulphatase5, the unconjugated parent compounds were identified by paper chromatography.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Richter, D., J. Physiol., 98, 361 (1940).
Richter, D., and MacIntosh, F. C., Am. J. Physiol., 135, 1 (1941).
Holtz, P., and Credner, K., Arch. expl. Path. Pharmak., 200, 356 (1942).
Shaw, K. N. F., McMillan, A., and Armstrong, M. D., J. biol. Chem., 226, 255 (1957).
Alton, H., and Goodall, McC., Biochem. Pharmac., 18, 1373 (1969).
Goodall, McC.,and Alton, H., Biochem. Pharmac., 21, 2401 (1972).
Williams, R. T., Biochem. J., 32, 878 (1938).
Deichman, W. B., Proc. Soc. expl. biol. Med., 54, 335 (1943).
Cotzias, G. C., Papavasiliou, P. S., and Gellene, R., New Engl. J. Med., 280, 337 (1969).
L-Dopa and Parkinsonism (edit. by Barbeau, A., and McDowell, F. H.) (Davis, Philadelphia, 1970).
Weil-Malherbe, H., and Van Buren, J. M., J. Lab. clin. Med., 74, 305 (1969).
Rayfield, E. J., Cain, J. P., Casey, M. P., Williams, G. H., and Sullivan, J. M., J. Am. med. Ass., 221, 704 (1972).
Weil-Malherbe, H., Methods of Biochemical Analysis, 16, 293 (1968).
Smith, E. R. B., and Weil-Malherbe, H., Clinica chim. Acta, 35, 505 (1971).
Anton, A. H., and Sayre, D. F., J. Pharmac. expl. Ther., 145, 326 (1964).
Sourkes, T. L., Denton, R. L., Murphy, G. F., Chavez, B., and Saint Cyr, S., Pediatrics, 31, 660 (1963).
Sato, T. L., J. Lab. clin. Med., 66, 517 (1965).
Hawk, P. B., Oser, B. L., and Summerson, W. H., Practical Physiological Chemistry, 946 (McGraw Hill, New York, 1954).
Berglund, F., and Sörbo, B., Scand. J. clin. Lab. Invest., 12, 147 (1960).
Maughan, G. B., Evelyn, K. A., and Browne, S. L., J. biol. Chem., 126, 567 (1938).
Williams, R. T., Detoxication Mechanisms, 284 (Wiley, New York, 1959).
Bray, H. G., Humphris, B. G., Thorpe, W. V., White, K., and Wood, P. B., Biochem. J., 52, 419 (1952).
Young, L., and Maw, G. A., The Metabolism of Sulphur Compounds, 108 (Methuen, London, 1958).
Häggendal, J., Acta physiol. scand., 59, 255 (1963).
Morgan, C. D., Ruthven, C. R. J., and Sandler, M., Clinica chim. Acta, 26, 381 (1969).
Nose, Y., and Lipmann, F., J. biol. Chem., 233, 1348 (1958).
Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., and Kopin, I. J., Biochem. Pharmac., 17, 2006 (1968).
Hidaka, H., and Austin, J., Biochim. biophys. Acta, 268, 132 (1972).
Meek, J. L., and Neff, N. H., J. Pharmac. expl. Ther., 181, 457 (1972).
Mattock, G. L., Wilson, D. L., and Hoffer, A., Nature, 213, 1189 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
RUTLEDGE, C., HOEHN, M. Sulphate Conjugation and L-Dopa Treatment of Parkinsonian Patients. Nature 244, 447–450 (1973). https://doi.org/10.1038/244447b0
Received:
Revised:
Issue date:
DOI: https://doi.org/10.1038/244447b0
This article is cited by
-
Platelet phenolsulphotransferase activity in Parkinson's disease
Journal of Neural Transmission (1983)
-
In vivo assessment of decarboxylase inhibition or potentiation: Urinary dopamine and L-Dopa output after L-Dopa administration
Journal of Neural Transmission (1976)
-
Thin-layer chromatography for diagnosis of secreting neuroblastoma
European Journal of Pediatrics (1975)
-
Dopamine 3-O-sulphate, an end product of L-dopa metabolism in Parkinson patients
Nature (1974)